Lv311
260 积分 2024-03-11 加入
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
12小时前
已完结
Primary Myelofibrosis: Update on Definition, Pathogenesis, and Treatment
6天前
已完结
Important Pathologic Considerations for Establishing the Diagnosis of Myelofibrosis
6天前
已关闭
Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases
13天前
已完结
Frequency of somatic and germline variants of predisposition genes in young Chinese women with breast cancer
14天前
已完结
Implementation of Bispecific Antibodies in the Community: Lessons From the ThedaCare Cancer Center Experience
22天前
已完结
The impact of starting dose on overall survival in myelofibrosis patients treated with ruxolitinib: A prospective real‐world study on AIFA monitoring registries
1个月前
已完结
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry
1个月前
已完结
A Journey Through JAK Inhibitors for the Treatment of Myeloproliferative Diseases
1个月前
已完结
How I treat anemia in myelofibrosis
1个月前
已完结
皖公网安备34019202002308
